Tivozanib multi target TKI



Trial Studied treatment Control Patients Size Study type Results NCT

Renal-cell carcinoma (advanced) - multi target TKI in all type of patients

TIVO-1, 2013tivozanibsorafenib517 (260/257) NCT01030783



- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons